Palo Alto, TX, United States of America

An Song

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: An Song. Retrieved from https://idiyas.com/inventor/an-song-6pbsnbpy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Song - Innovator in Antibody Research

Introduction

An Song is a prominent inventor based in Palo Alto, Texas. He has made significant contributions to the field of antibody research. His work focuses on novel approaches that can lead to advancements in medical treatments.

Latest Patents

An Song holds a patent for "Novel LILRB2 Antibodies and Uses Thereof." This patent represents a crucial step in the development of therapeutic antibodies that target specific proteins involved in various diseases. His innovative approach has the potential to impact treatment methodologies significantly.

Career Highlights

An Song is affiliated with The University of Texas System, where he conducts his research. His academic background and expertise in the field have positioned him as a key figure in antibody innovation. He has dedicated his career to exploring new avenues in medical science.

Collaborations

An Song collaborates with Ningyan Zhang, enhancing the research efforts in their field. Their partnership exemplifies the importance of teamwork in scientific discovery.

Conclusion

An Song's contributions to antibody research and his innovative patent highlight his role as a leading inventor in the scientific community. His work continues to pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…